Back

Panel discussion.

26 August 2022 (16:00 - 16:15)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022? Chronic Heart Failure, Other Open Access ESC Congress 2022

About the speaker

Photo
Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

3 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
What is the evidence for SGLT2 inhibitors in HF?
Professor I. Pina (Philadelphia, US)
Slides Video
Presentation thumbnail
SGLT2 inhibitors for HF treatments in 2022 - What do the guidelines tell us?
Professor G. Rosano (London, GB)
Slides Video

Access the full session

Session thumbnail
SGLT2 inhibitors in practice (part 1): what is the state of heart failure treatment in 2022?
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 16:00 CET
You may be interested in
thumbnail
Congress Session
SGLT2 inhibitors in practice (part 3): the case for early intervention in HFrEF
27 August 2022
thumbnail
Congress Presentation
Panel discussion.
28 August 2022
thumbnail
Congress Presentation
Panel discussion: how to start treatment with SGLT2 inhibitors in patients with heart failure
27 August 2023
thumbnail
Congress Session
Therapy in action: optimising heart failure care with SGLT2 inhibitors for outpatients
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources